Sarah Schram

Stock Analyst at William Blair

(n/a)

# 4,544

Out of 4,820 analysts

Total ratings

n/a

Success rate

-25.27%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Sarah Schram

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	DNLI Denali Therapeutics	Initiates: Outperform	n/a	$15.67	-	1	Jan 3, 2025
	VIGL Vigil Neuroscience	Initiates: Outperform	n/a	$1.79	-	1	Dec 4, 2024

Denali Therapeutics

Jan 3, 2025

Initiates: Outperform

Price Target: n/a

Current: $15.67

Upside: -

Vigil Neuroscience

Dec 4, 2024

Initiates: Outperform

Price Target: n/a

Current: $1.79

Upside: -